Tyrosine kinase inhibitors and epidermal growth factor receptor (egfr) mutations in non-small cell lung cancer: To test or not to test?

Adi F. Gazdar

Research output: Contribution to journalComment/debatepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Tyrosine kinase inhibitors and epidermal growth factor receptor (egfr) mutations in non-small cell lung cancer: To test or not to test?'. Together they form a unique fingerprint.